We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+3.35%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$54.2B
AUM Growth
-$1.5B
Cap. Flow
-$2.46B
Cap. Flow %
-4.53%
Top 10 Hldgs %
9.23%
Holding
3,766
New
402
Increased
1,315
Reduced
1,324
Closed
445

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$549M
2
CVS icon
CVS Health
CVS
+$537M
3
META icon
Meta Platforms (Facebook)
META
+$515M
4
MCD icon
McDonald's
MCD
+$386M
5
HD icon
Home Depot
HD
+$308M

Sector Composition

Rank Sector Weight
1 Healthcare 11.4%
2 Consumer Discretionary 10.14%
3 Technology 10.06%
4 Financials 9.8%
5 Industrials 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKBA icon
3176
Akebia Therapeutics
AKBA
$327M
$183K ﹤0.01%
24,485
-3,215
-12% -$28.1K
CNX icon
3177
CNX Resources
CNX
$4.85B
$182K ﹤0.01%
13,549
-606,093
-98% -$7.09M
AMD icon
3178
CALL
Advanced Micro Devices
AMD
$851B
$176K ﹤0.01%
+34,300
New +$133K
CGEN icon
3179
Compugen
CGEN
$216M
$172K ﹤0.01%
26,526
+7,125
+37% +$47.6K
PFSW
3180
DELISTED
PFSweb, Inc.
PFSW
$169K ﹤0.01%
17,839
+32
+0.2% +$411
FRO icon
3181
Frontline
FRO
$8.75B
$157K ﹤0.01%
19,934
+8,656
+77% +$71.1K
GPT
3182
DELISTED
Gramercy Property Trust
GPT
$157K ﹤0.01%
5,676
+966
+21% +$25.4K
CDR
3183
DELISTED
Cedar Realty Trust, Inc
CDR
$154K ﹤0.01%
+3,141
New +$146K
PNNT
3184
Pennant Park Investment Corp
PNNT
$215M
$153K ﹤0.01%
22,402
-13,981
-38% -$90.4K
AAMI
3185
Acadian Asset Management
AAMI
$2.88B
$151K ﹤0.01%
+11,330
New +$158K
CDMO
3186
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$149K ﹤0.01%
58,635
+34,716
+145% +$96.8K
HRTG icon
3187
Heritage Insurance Holdings
HRTG
$842M
$148K ﹤0.01%
12,334
-2,179
-15% -$29K
ACGN
3188
DELISTED
Aceragen Inc
ACGN
$145K ﹤0.01%
699
-119
-15% -$26.2K
CLF icon
3189
PUT
Cleveland-Cliffs
CLF
$6.81B
$142K ﹤0.01%
25,000
REXI
3190
DELISTED
RESOURCE AMERICA INC CL-A
REXI
$142K ﹤0.01%
14,635
-2,130
-13% -$16.4K
LEAF
3191
DELISTED
Leaf Group Ltd.
LEAF
$141K ﹤0.01%
27,258
-183,595
-87% -$1.01M
DCOY
3192
Decoy Therapeutics
DCOY
$2.68M
0
BKCC
3193
DELISTED
BlackRock Capital Investment Corporation
BKCC
$140K ﹤0.01%
18,033
+3,677
+26% +$30.4K
FTK icon
3194
Flotek Industries
FTK
$935M
$138K ﹤0.01%
1,743
-53,796
-97% -$3.44M
CALA
3195
DELISTED
Calithera Biosciences, Inc
CALA
$138K ﹤0.01%
1,862
+139
+8% +$13.9K
WK icon
3196
Workiva
WK
$2.94B
$137K ﹤0.01%
+10,013
New +$127K
EGLT
3197
DELISTED
Egalet Corporation
EGLT
$137K ﹤0.01%
27,585
+13,615
+97% +$80.7K
RXDX
3198
DELISTED
Ignyta, Inc.
RXDX
$135K ﹤0.01%
+24,867
New +$165K
TITN icon
3199
Titan Machinery
TITN
$466M
$133K ﹤0.01%
11,939
+850
+8% +$9.77K
ARDX icon
3200
Ardelyx
ARDX
$1.24B
$132K ﹤0.01%
15,098
-45,283
-75% -$370K

Similar funds

D.E. Shaw & Co's Q2 2016 Portfolio in Review

As of Q2 2016, D.E. Shaw & Co held 3,766 positions worth $54.2B, down 2.7% from $55.7B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

D.E. Shaw & Co withdrew a net $2.46B in Q2 2016, closing 445 positions and reducing 1,324 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $369M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, D.E. Shaw & Co opened a new position in Liberty Media Corporation Series C Liberty SiriusXM Common Stock worth $198M.

  • D.E. Shaw & Co's largest Q2 2016 buy was Liberty Media Corporation Series C Liberty SiriusXM Common Stock: 8,430,023 shares worth $198M.
  • D.E. Shaw & Co added most to Amazon in Q2 2016, an estimated $549M increase.
  • D.E. Shaw & Co's biggest Q2 2016 reduction was Booking.com, cutting an estimated $475M.
  • D.E. Shaw & Co fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $369M.
  • D.E. Shaw & Co's ten largest holdings make up 9.2% of its $54.2B portfolio in Q2 2016.
  • D.E. Shaw & Co opened 402 new positions and closed 445 in Q2 2016.
  • D.E. Shaw & Co's portfolio value fell 2.7% quarter-over-quarter to $54.2B.

Based on D.E. Shaw & Co's 13F filing for Q2 2016, filed 15 Aug 2016.